Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation - PubMed (original) (raw)
. 1997 Jan 17;272(3):1500-6.
doi: 10.1074/jbc.272.3.1500.
Affiliations
- PMID: 8999820
- DOI: 10.1074/jbc.272.3.1500
Free article
Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation
C S Zong et al. J Biol Chem. 1997.
Free article
Abstract
The signaling functions of the oncogenic protein-tyrosine kinase v-Ros were studied by systematically mutating the tyrosine residues in its cytoplasmic domain. The carboxyl mutation of Tyr-564 produces the most pronounced inhibitory effect on v-Ros autophosphorylation and interaction with phospholipase Cgamma. A cluster of 3 tyrosine residues, Tyr-414, Tyr-418, and Tyr-419, within the PTK domain of v-Ros plays an important role in modulating its kinase activity. The mutant F419 and the mutant DI, deleting 6-amino acids near the catalytic loop, retain wild type protein tyrosine kinase and mitogenic activities, but have dramatically reduced oncogenicity. Both mutant proteins are able to phosphorylate or activate components in the Ras/microtubule-associated protein kinase signaling pathway. However, F419 mutant protein is unable to phosphorylate insulin receptor substrate 1 (IRS-1) or promote association of IRS-1 with phosphatidylinositol 3-kinase. This tyrosine residue in the context of the NDYY motif may define a novel recognition site for IRS-1. Both F419 and DI mutants display impaired ability to induce tyrosine phosphorylation of a series of cytoskeletal and cell-cell interacting proteins. Thus the F419 and DI mutations define v-Ros sequences important for cytoskeleton signaling, the impairment of which correlates with the reduced cell transforming ability.
Similar articles
- Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor.
Jiang Y, Chan JL, Zong CS, Wang LH. Jiang Y, et al. J Biol Chem. 1996 Jan 5;271(1):160-7. doi: 10.1074/jbc.271.1.160. J Biol Chem. 1996. PMID: 8550552 - Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL, Blakesley VA, Koval AP, Scrimgeour AG, LeRoith D. Esposito DL, et al. Endocrinology. 1997 Jul;138(7):2979-88. doi: 10.1210/endo.138.7.5281. Endocrinology. 1997. PMID: 9202243 - Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors.
Chan JL, Lai M, Wang LH. Chan JL, et al. J Biol Chem. 1997 Jan 3;272(1):146-53. doi: 10.1074/jbc.272.1.146. J Biol Chem. 1997. PMID: 8995240 - [The role of phosphorylation cascade in insulin action].
Tobe K, Ueki K, Tamemoto H, Kaburagi Y, Honda R, Kadowaki T. Tobe K, et al. Nihon Rinsho. 1994 Oct;52(10):2673-85. Nihon Rinsho. 1994. PMID: 7983797 Review. Japanese.
Cited by
- EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis.
Shih CH, Chang YJ, Huang WC, Jang TH, Kung HJ, Wang WC, Yang MH, Lin MC, Huang SF, Chou SW, Chang E, Chiu H, Shieh TY, Chen YJ, Wang LH, Chen L. Shih CH, et al. Oncogene. 2017 Nov 23;36(47):6542-6554. doi: 10.1038/onc.2017.262. Epub 2017 Jul 31. Oncogene. 2017. PMID: 28759046 Free PMC article. - Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation.
Li W, Jiang YX, Zhang J, Soon L, Flechner L, Kapoor V, Pierce JH, Wang LH. Li W, et al. Mol Cell Biol. 1998 Oct;18(10):5888-98. doi: 10.1128/MCB.18.10.5888. Mol Cell Biol. 1998. PMID: 9742106 Free PMC article. - Novel insight into mechanisms of ROS1 catalytic activation via loss of the extracellular domain.
Jones K, Keddy C, Jenkins C, Nicholson K, Shinde U, Davare MA. Jones K, et al. Sci Rep. 2024 Sep 27;14(1):22191. doi: 10.1038/s41598-024-71687-7. Sci Rep. 2024. PMID: 39333184 Free PMC article. - Multifunctional bioactive glass nanoparticles: surface-interface decoration and biomedical applications.
Chen M, Wang Y, Yuan P, Wang L, Li X, Lei B. Chen M, et al. Regen Biomater. 2024 Sep 6;11:rbae110. doi: 10.1093/rb/rbae110. eCollection 2024. Regen Biomater. 2024. PMID: 39323748 Free PMC article. Review.